2025年，私募业迎来高光时刻，行业总规模一举突破22万亿大关，一批私募规模破百亿，大量产品净值创 下历史新高。 尽管11月A股市场震荡整固，百亿私募业绩略有回撤，但不少私募依然交出了正收益，今年以来的累计收益更 是大幅跑赢指数。 值得注意的是，今年以来，量化业绩表现抢眼，不少头部私募的超额收益高达30%，最火热的当数中小市值指 增策略。 券商中国记者从渠道获悉，源乐晟、新思哲、复胜、同犇、彤源等多家主观私募旗下代表产品年内业绩超过 50%；量化私募更加抢眼，背后是中小指增策略的火爆，明汯、世纪前沿、蒙玺、龙旗等多家百亿量化旗下的 1000和2000指增产品业绩超60%。 私募业绩大爆发 11月，A股市场进入震荡调整阶段，结构分化与板块轮动显著加快。在此背景下，百亿私募基金虽阶段性承 压，但整体表现优于主要指数，展现出较强的风险应对能力。 私募排排网统计数据显示，截至2025年11月底，有业绩展示的73家百亿私募在11月整体微跌0.27%，其中42家 实现正收益，占比为57.53%。其中，量化私募逆势走强，有业绩展示的45家百亿量化私募当月整体收益为 0.66%。 从全年维度看，百亿私募在1—11月的整体收益 ...

年内私募业绩大丰收 量化产品领跑 中小市值策略火爆 证券时报记者 许孝如 尽管近期A股市场震荡回调，百亿私募业绩有所回撤，但不少私募11月份依然交出正收益，今年以来的 累计收益更是大幅跑赢指数。 私募排排网数据显示，整体来看，45家百亿量化私募中，仅5家收益率低于20%，26家百亿量化私募收 益率在20%～39.99%，14家私募收益率超过40%。 证券时报记者获悉，源乐晟、新思哲、复胜、同犇、彤源等多家主观私募旗下的代表产品，年内收益率 已超50%。相比之下，量化私募的业绩表现更为亮眼，这背后离不开中小指增策略的持续火爆，明汯、 世纪前沿、蒙玺、龙旗等多家百亿量化机构旗下的中证1000及中证2000指增产品，收益率更是突破了 60%。 私募业绩大爆发 11月，A股市场进入震荡调整阶段，结构分化与板块轮动显著加快。在此背景下，百亿私募基金虽然阶 段性承压，但整体表现优于主要指数，展现出较强的风险应对能力。 私募排排网统计数据显示，截至2025年11月底，有业绩展示的73家百亿私募在11月整体微跌0.27%，其 中42家实现正收益，占比为57.53%。其中，量化私募逆势走强，有业绩展示的45家百亿量化私募当月 ...

证券时报记者获悉，源乐晟、新思哲、复胜、同犇、彤源等多家主观私募旗下的代表产品，年内收益率 已超50%。相比之下，量化私募的业绩表现更为亮眼，这背后离不开中小指增策略的持续火爆，明汯、 世纪前沿、蒙玺、龙旗等多家百亿量化机构旗下的中证1000及中证2000指增产品，收益率更是突破了 60%。 人民财讯12月12日电，尽管近期A股市场震荡回调，百亿私募业绩有所回撤，但不少私募11月份依然交 出正收益，今年以来的累计收益更是大幅跑赢指数。 ...

尽管近期A股市场震荡回调，百亿私募业绩有所回撤，但不少私募11月份依然交出正收益，今年以来的 累计收益更是大幅跑赢指数。 证券时报记者获悉，源乐晟、新思哲、复胜、同犇、彤源等多家主观私募旗下的代表产品，年内收益率 已超50%。相比之下，量化私募的业绩表现更为亮眼，这背后离不开中小指增策略的持续火爆，明汯、 世纪前沿、蒙玺、龙旗等多家百亿量化机构旗下的中证1000及中证2000指增产品，收益率更是突破了 60%。 私募业绩大爆发 11月，A股市场进入震荡调整阶段，结构分化与板块轮动显著加快。在此背景下，百亿私募基金虽然阶 段性承压，但整体表现优于主要指数，展现出较强的风险应对能力。 私募排排网统计数据显示，截至2025年11月底，有业绩展示的73家百亿私募在11月整体微跌0.27%，其 中42家实现正收益，占比为57.53%。其中，量化私募逆势走强，有业绩展示的45家百亿量化私募当月 整体收益率为0.66%。 从全年维度看，百亿私募在前11个月的整体收益率达29.44%，其中71家实现正收益，占比高达 97.26%。在实现正收益的机构中，33家落在20%～39.99%区间，更有19家收益率超过40%。 证券时报 ...

Core Insights - Deepseek has emerged as a significant player in the global AI landscape, revitalizing the quantitative investment sector, particularly in a market environment favoring small and mid-cap stocks [2] - In November, despite an overall adjustment in the A-share market, many quantitative products from billion-yuan private equity firms achieved historical highs, with quantitative products accounting for over 80% of these successes [2] - The average return for 1,833 quantitative products this year is 26.98%, with an excess (geometric) return of 11.41% [2][3] Quantitative Investment Performance - The average return for quantitative long strategies is 40.34%, with an excess return of 17.25%, making it the top performer among secondary strategies [3] - The performance of various quantitative strategies is summarized as follows: - Quantitative CTA: 16.32% average return, 13.76% excess return - Stock market neutral: 9.37% average return, -4.93% excess return - Composite strategies: 23.85% average return, 7.61% excess return - Options strategies: 11.04% average return, 8.60% excess return - Convertible bond trading strategies: 20.42% average return, 3.65% excess return - Arbitrage strategies: 11.63% average return, -2.96% excess return - Macro strategies: 21.72% average return, 5.69% excess return - Stock long-short: 15.05% average return, 0.01% excess return - FOF: 13.50% average return, -1.33% excess return - Bond composite strategies: 13.88% average return, 13.15% excess return - Pure bond strategies: 6.47% average return, 5.79% excess return - Other derivative strategies: 37.74% average return, 34.72% excess return - Bond enhancement: 11.47% average return, 10.76% excess return [3] Top Performing Quantitative Products - The "quantitative stock selection" products have an average return of 39.40% and an average excess return of 19.14% [4] - The top three products in the "quantitative stock selection" category are from: - Zhuhai Zhengfeng Private Equity - Shui Du Quan Asset - Jiu Ming Investment [5] - The "CSI 500 index enhancement" products have an average return of 40.17% and an average excess return of 14.14% [8] - The top three products in the "CSI 500 index enhancement" category are from: - Zhaoxin Private Equity Fund - Guobiao Asset - Zhaoyue Private Equity [9] - The "CSI 1000 index enhancement" products have an average return of 44.68% and an average excess return of 17.53% [13] - The top three products in the "CSI 1000 index enhancement" category are from: - Jintong Investment - Luxiu Investment - Mengxi Investment [13] Other Notable Strategies - The "CSI 300 index enhancement" products have an average return of 24.47% and an average excess return of 8.20% [17] - The top three products in the "CSI 300 index enhancement" category are from: - Hainan Pengpai Private Equity - Ningbo Huansheng Quantitative - Mingyun Investment [17] - The "other index enhancement" products have an average return of 42.58% and an average excess return of 20.13% [20] - The top three products in the "other index enhancement" category are from: - Yangshi Asset - Luxiu Investment - Shengguanda [21]

Group 1 - DeepSeek has gained global attention due to its technological breakthroughs and its unique stance of not seeking external financing, which highlights the management's financial strength [1] - The company is backed by a well-established cash flow generator, which has recently come to light, altering the perception of DeepSeek's operational model [1] Group 2 - Huanfang Quantitative, founded by Liang Wenfeng, has seen a significant performance resurgence, with its stock long/short strategy yielding approximately 50% returns in the first eleven months of 2025, outperforming the CSI 1000 and CSI 500 indices by about 30 percentage points [2][5] - This resurgence is attributed to the revival of classic factors in the market, particularly in the crowded areas of the CSI 1000 and CSI 500 indices, indicating a return to effective strategies after a period of underperformance [5][6] Group 3 - Huanfang's asset management scale reportedly shrank to around 20 billion yuan, leading to decreased market attention as focus shifted to larger firms with over 50 billion yuan in assets [7][8] - Despite the reduction in external management scale, Huanfang's internal self-managed portfolio has remained a critical support for its business, although specific performance figures for this internal portfolio are not publicly disclosed [10][15] Group 4 - The performance of Huanfang's external asset management products, which have maintained around 50% returns, suggests that the internal self-managed portfolio likely mirrors this success, if not exceeding it [16] - The resurgence of Huanfang's performance may indicate potential shifts in the private equity landscape and could signal an increased investment in large model initiatives within China [17]

Core Viewpoint - Quantitative products are systematic investment methods based on mathematical models, algorithms, and computer technology, with the ability to generate excess returns being a key indicator of their effectiveness [2] Group 1: Quantitative Excess Rate - The quantitative excess rate is defined as the frequency or probability of a quantitative strategy outperforming a benchmark index over a certain period, calculated as the number of times it beats the benchmark divided by the total observation periods [2] - A higher quantitative excess rate indicates that the strategy can maintain positive excess returns most of the time, reducing the risk of significant drawdowns or prolonged underperformance [2] Group 2: Performance of Billion-Level Quantitative Private Equity - In 2023, 388 quantitative products from billion-level private equity firms achieved an average return of 34.26%, with an excess return of 10.87% and an average excess rate of 61.33%, significantly leading among various scales of private equity [3] - The average performance metrics for different scales of private equity are as follows: - 100 billion and above: 34.26% return, 10.87% excess, 61.33% excess rate - 50-100 billion: 25.20% return, 8.14% excess, 56.48% excess rate - 20-50 billion: 27.19% return, 10.77% excess, 55.91% excess rate - 10-20 billion: 26.56% return, 8.95% excess, 54.63% excess rate - 5-10 billion: 26.05% return, 8.99% excess, 53.59% excess rate - 0-5 billion: 24.37% return, 10.11% excess, 52.63% excess rate - Total: 27.64% return, 9.90% excess, 55.86% excess rate [3] Group 3: Top Performers in Quantitative Strategies - The top three products with the highest excess rates in the CSI 300 index enhancement category are from Minghuo Investment, Ningbo Huanfang Quantitative, and Kuande Private Equity, with the average excess rate for billion-level private equity in this category being 64.59% [4] - In the CSI 500 index enhancement category, the top three products are from Wanyan Asset, Pansong Asset, and Tianyan Capital, with an average excess rate of 67.28% for billion-level private equity [10] - In the CSI 1000 index enhancement category, the top three products are from Microbo Yi, Mengxi Investment, and Yanfeng Investment, with an average excess rate of 76.17% for billion-level private equity [10] Group 4: Quantitative Stock Selection - The average return for quantitative stock selection products in 2023 is 40.45%, with an excess return of 16.55% and an average excess rate of 58.26%, while billion-level private equity in this category has an average excess rate of 65.97% [13] - The top three products in this category are from Jiukun Investment, Tianyan Capital, and Longqi Technology [13]

Core Insights - The A-share market has entered a volatile rotation phase since October, with significant recovery in the returns of quantitative products [2] - Among the 825 quantitative long products with performance data, the average return for the year is 41.02%, with an excess return of 14.36% [3] Summary by Category Performance of Strategies - Quantitative long products have the highest average return in October among all stock strategy products, reaching 0.93% with an average excess return of 1.5% [2] - The performance of various strategies is as follows: - Quantitative long: 825 products, average return 41.02%, monthly return 0.93% [3] - Subjective long: 2156 products, average return 36.11%, monthly return -1.35% [3] - Macro strategy: 201 products, average return 27.17%, monthly return 0.96% [3] - Composite strategy: 409 products, average return 25.66%, monthly return 1.11% [3] - Other derivative strategies: 15 products, average return 25.63%, monthly return 4.45% [3] Top Performing Products - In the quantitative long category, the top products by excess return include: - CSI 1000 index enhancement: 158 products, average return 45.51%, excess return 15.48% [4] - Quantitative stock selection: 329 products, average return 39.25%, excess return 15.56% [4] - CSI 500 index enhancement: 201 products, average return 42.07%, excess return 10.96% [4] - CSI 300 index enhancement: 38 products, average return 25.62%, excess return 6.52% [4] - Other index enhancements: average return 43.55%, excess return 18.52% [4] Notable Fund Managers - The top products in the CSI 1000 index enhancement category are managed by notable fund managers from large private equity firms, with the highest returns coming from companies like Jintong Investment and Luxiu Investment [5][9] - In the quantitative stock selection category, the top products are managed by firms such as Longqi Technology and Jiuming Investment [10][12] - The CSI 500 index enhancement products are led by managers from Guobiao Asset and Zhaoxin Private Fund [13][16] - The CSI 300 index enhancement products are managed by firms like Hainan Pengpai Private Fund and Ningbo Huansquare Quantitative [17][20] - Other index enhancement products are managed by firms such as Liangchuang Investment and Yangshi Asset [21][23]

Core Viewpoint - The private equity index enhancement strategies have shown strong excess return capabilities in the first three quarters of this year, particularly among billion-level quantitative private equity managers, who leverage refined factor extraction and strict risk control systems to maintain their leading advantages [2][4]. Group 1: Performance Overview - As of the end of September, the average annual return of 231 billion-level quantitative private equity index enhancement products was 43.82%, with an average excess return of 14.89% [2]. - The quantitative stock selection and CSI 1000 index enhancement products led in excess returns [2]. - The average excess return for the CSI 500 index enhancement products was 10.71%, with an average drawdown of 4.44% [6]. Group 2: Top Performers - The top performers in the CSI 500 index enhancement category included companies like 顽岩资产, 鸣石基金, and 世纪前沿, showcasing strong excess return capabilities [5][6]. - 明汯投资's "明汯价值成长1期B号" and 蒙玺投资's "蒙玺中证1000指数量化5号A类份额" were highlighted as top products in the CSI 1000 index enhancement category [10][12]. - 龙旗科技's "龙旗科技创新精选1号C类份额" achieved the highest excess return in the quantitative stock selection category [14][16]. Group 3: Strategy Insights - The CSI 1000 index enhancement products are noted for their potential to exploit mispricing opportunities due to their large number of constituent stocks and low institutional coverage [10]. - The quantitative stock selection strategy, which relies on multi-factor models to identify stocks with expected excess returns, has shown an average excess return of 23.63% [14]. - The average return for quantitative stock selection products was 49.43%, with an average drawdown of 6.91% [14]. Group 4: Other Index Enhancements - Other index enhancement strategies, including CSI 2000 and national index enhancements, reported an average excess return of 14.92% and an average drawdown of 3.90% [17][19]. - Companies like 聚宽投资 and 微观博易 were recognized among the top performers in the other index enhancement category [17][19].

Core Insights - The median excess return of index-enhanced products has significantly improved compared to last year [1] - The China Securities 1000 index-enhanced products have shown particularly outstanding excess returns, followed by the China Securities 500 index-enhanced products [1] Group 1: Market Dynamics - The strong performance of public index-enhanced products this year is attributed to two main factors: accelerated rotation among market sectors and overall activity in small-cap stocks [1] - There is a noticeable cycle of rotation between large-cap and small-cap stocks in the Chinese market, with the current small-cap advantage cycle starting in 2021 [1] Group 2: Investment Strategy - Future index profitability and growth potential should be considered for index allocation, alongside short-term factors such as valuation and market sentiment [1]